RESÚMENES JUNIO 2008

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium–valproate maintenance therapy with healthy controls

E Kurt, M Emul, O Ozbulut, O Guler, F Erdur, H Saglam, and O Gecici

Journal of Psychopharmacology 2008, First published on May 30, 2008

 

3< - The influences of depression and venlafaxine use at therapeutic doses on atrial conduction

M Emul, M Dalkiran, S Samim, E Yildirim, R Bayar, I Balcioglu, and I Keles

Journal of Psychopharmacology 2008, First published on May 30, 2008

3 - The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study

A Tint, P M Haddad, and I M Anderson

Journal of Psychopharmacology 2008, First published on May 30, 2008

3 - Cortical 5-hydroxytryptamine2A-receptor mediated excitatory synaptic currents in the rat following repeated daily fluoxetine administration

Gerard J. MarekCorresponding Author Contact Information, a, E-mail The Corresponding Author

Neuroscience Letters. Volume 438, Issue 3, 27 June 2008, Pages 312-316

 

3! - Gender differences in the association of mixed anxiety and depression with suicide

Ottar Bjerkeset, Pål Romundstad, David Gunnell

The British Journal of Psychiatry (2008) 192: 474-475

3! - Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients

Philip Gorwood, Emmanuelle Corruble, Bruno Falissard, and Guy M. Goodwin

Am J Psychiatry 2008; 165:731-739

3! - Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy

Adrienne Einarson, Alessandra Pistelli, Marco DeSantis, Heli Malm, Wolfgang D. Paulus, Alice Panchaud, Debra Kennedy, Thomas R. Einarson, and Gideon Koren

Am J Psychiatry 2008; 165:749-752

3 - Sleep and Circadian Rhythms in Bipolar Disorder: Seeking Synchrony, Harmony, and Regulation

Allison G. Harvey

Am J Psychiatry Published June 2, 2008

3! - Disturbed sleep in post-traumatic stress disorder: Secondary symptom or core feature?

Victor I. Spoormaker Corresponding Author Contact Information, 1, a, E-mail The Corresponding Authorand Paul Montgomery2, a, E-mail The Corresponding Author

Sleep Medicine Reviews. Volume 12, Issue 3, June 2008, Pages 169-184

 

3! - Minor Increase in Risk of Road Traffic Accidents After Prescriptions of Antidepressants: A Study of Population Registry Data in Norway

Jørgen G. Bramness, Svetlana Skurtveit, C. Ineke Neutel, Jørg Mørland, and Anders Engeland

J Clin Psychiatry June 3, 2008: e1-e5

 

3 - Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: Diagnostic- and Symptom-Guided Drug Selection

Somaia Mohamed, and Robert A. Rosenheck

J Clin Psychiatry June 3, 2008: e1-e7

 

5 - Vitamins B12, B6, and Folic Acid for Onset of Depressive Symptoms in Older Men: Results From a 2-Year Placebo-Controlled Randomized Trial

Andrew H. Ford, Leon Flicker, Jenny Thomas, Paul Norman, Konrad Jamrozik, and Osvaldo P. Almeida

J Clin Psychiatry June 10, 2008: e1-e7

 

4 - Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials

Lam, Raymond W; Andersen, Henning F; Wade, Alan G

International Clinical Psychopharmacology. 23(4):181-187, July 2008

4 - A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder

Lieberman, Daniel Z; Montgomery, Stuart A; Tourian, Karen A; Brisard, Claudine; Rosas, Gregory; Padmanabhan, Krishna; Germain, Jean-Michel; Pitrosky, Bruno

International Clinical Psychopharmacology. 23(4):188-197, July 2008

3 - Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study

Altamura, Alfredo Carlo; Dell'Osso, Bernardo; Buoli, Massimiliano; Bosi, Monica; Mundo, Emanuela

International Clinical Psychopharmacology. 23(4):198-202, July 2008

3! - Tolerability of Selective Serotonin Reuptake Inhibitors: Issues Relevant to the Elderly

Draper, Brian; Berman, Karen

Drugs & Aging. 25(6):501-519, 2008

3 - Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

Ixchel Herrera-Guzmána, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Esteve Gudayol-Ferréa, b, Jennifer Lira-Mandujanob, Jorge Herrera-Abarcaa, c, Daniel Herrera-Guzmána, d, Karina Montoya-Pérezb and Joan Guardia-Olmos

Psychiatry Research. Volume 160, Issue 1, 15 July 2008, Pages 72-82

 

3! - The persistence of the placebo response in antidepressant clinical trials

Arif Khana, b, Corresponding Author Contact Information, E-mail The Corresponding Author, Nick Reddinga and Walter A. Brownc

Journal of Psychiatric Research. Volume 42, Issue 10, August 2008, Pages 791-796

 

3! - Age-specific familial risks of depression: A nation-wide epidemiological study from Sweden

Xinjun LiCorresponding Author Contact Information, a, E-mail The Corresponding Author, Jan Sundquista and Kristina Sundquist

Journal of Psychiatric Research. Volume 42, Issue 10, August 2008, Pages 808-814

 

3< - Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study

Peter Braunig;  Emilio Sacchetti; Rossella Medori

International Journal of Psychiatry in Clinical Practice, Volume 12, Issue 1 2008, pages 74 - 77

 

3 - Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Åsberg Depression Rating Scale for major depressive disorders in Japanese patients
Hisashi Higuchi, Kazuhiro Sato, Keizo Yoshida, Hitoshi Takahashi, Mitsuhiro Kamata, Koichi Otani, Noboru Yamaguchi

Psychiatry and Clinical Neurosciences 2008; 62 (3), 301–306

 

5 - Efficacy and Tolerability of Milnacipran in the Treatment of Major Depression in Comparison with Other Antidepressants: A Systematic Review and Meta-Analysis

Nakagawa, Atsuo; Watanabe, Norio; Omori, Ichiro M; Barbui, Corrado; Cipriani, Andrea; McGuire, Hugh; Churchill, Rachel; Furukawa, Toshi A; on behalf of the Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group

CNS Drugs. 22(7):587-602, 2008

3 - Spotlight on Bupropion in Major Depressive Disorder

Dhillon, Sohita; Yang, Lily P H; Curran, Monique P

CNS Drugs. 22(7):613-617, 2008

3 - An Open-Label Pilot Study to Evaluate the Efficacy of Sildenafil Citrate in Middle-Aged Men With Late-Onset Dysthymia

Orr, Guy; Seidman, Stuart N; Weiser, Mark; Gershon, Ari A; Dubrov, Yael BA; Klein, Donald F

Journal of Nervous & Mental Disease. 196(6):496-500, June 2008

3 - Escitalopram versus IRSNa

B. Milleta, E-mail The Corresponding Author

L’Encephale. Vol 34 - N° 3 - Juin 2008 : p. 280 - 283

3< - A Preliminary Study of fMRI-Guided rTMS in the Treatment of Generalized Anxiety Disorder

Alexander Bystritsky, Jonas T. Kaplan, Jamie D. Feusner, Lauren E. Kerwin, Mitali Wadekar, Mark Burock, Allan D. Wu, and Marco Iacoboni

J Clin Psychiatry June 17, 2008: e1-e7

 

3! - Examining a Bidirectional Association Between Depressive Symptoms and Diabetes

Sherita Hill Golden, Mariana Lazo, Mercedes Carnethon, Alain G. Bertoni, Pamela J. Schreiner, Ana V. Diez Roux, Hochang Benjamin Lee, Constantine Lyketsos

JAMA. 2008;299(23):2751-2759


5 - Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis

I. M. Omori, N. Watanabe, A. Nakagawa, T. Akechi, A. Cipriani, C. Barbui, H. McGuire, R. Churchill, and T. A. Furukawa

Journal of Psychopharmacology First published on June 18, 2008

5 - Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis

W. W. van den Broek*, P. G. H. Mulder, E. van Os, T. K. Birkenhäger, E. Pluijms, and J. A. Bruijn

Journal of Psychopharmacology First published on June 18, 2008

3! - Effect of antidepressants on melatonin metabolite in depressed patients

L. Carvalho, C. Gorenstein, R. Moreno, C. Pariante, and R. Markus

Journal of Psychopharmacology First published on June 18, 2008

5 - Does oral alprazolam affect ventilation? A randomised, double-blind, placebo-controlled trial

G. E. Carraro, E. W. Russi, S. Buechi, and K. E. Bloch

Journal of Psychopharmacology First published on June 18, 2008

3 - Change in Seizure Threshold During Electroconvulsive Therapy

Fink, Max; Petrides, Georgios; Kellner, Charles; Mueller, Martina; Knapp, Rebecca; Husain, Mustafa M; Rasmussen, Keith; Rummans, Teri; O'Connor, Kevin; the CORE Group

Journal of ECT. 24(2):114-116, June 2008

3< - The Use of Electroconvulsive Therapy in the Elderly: A Study From the Psychiatric Unit of a North Indian Teaching Hospital

Jain, Gaurav; Kumar, Vineet; Chakrabarti, Subho; Grover, Sandeep

Journal of ECT. 24(2):122-127, June 2008

3 - The Effectiveness of Electroconvulsive Therapy in Treatment-Resistant Depression: A Naturalistic Study

Khalid, Najeeb; Atkins, Maria; Tredget, John; Giles, Maureen; Champney-Smith, Karen; Kirov, George

Journal of ECT. 24(2):141-145, June 2008

3 - A Dissociation Between Anterograde and Retrograde Amnesia After Treatment With Electroconvulsive Therapy: A Naturalistic Investigation

O'Connor, Margaret; Lebowitz, Brian K; Ly, Jenny; Panizzon, Matthew S; Elkin-Frankston, Seth; Dey, Sangeeta; Bloomingdale, Kerry; Thall, Mark; Pearlman, Chester

Journal of ECT. 24(2):146-151, June 2008

3! - Electroconvulsive Therapy, Brain-Derived Neurotrophic Factor, and Possible Neurorestorative Benefit of the Clinical Application of Electroconvulsive Therapy

Taylor, Stephen Michael

Journal of ECT. 24(2):160-165, June 2008

3 - Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study

Tatsuya Okamotoa, Reiji YoshimuraCorresponding Author Contact Information, a, E-mail The Corresponding Author, Atsuko Ikenouchi-Sugitaa, Hikaru Horia, Wakako Umene-Nakanoa, Yoshiaki Inouea, Nobuhisa Uedaa and Jun Nakamura

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 5, 1 July 2008, Pages 1185-1190

 

3< - The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression

Dorotea Muck-Selera, Corresponding Author Contact Information, E-mail The Corresponding Author, Marina Sagudb, Maja Mustapica, Gordana Nedica, Ana Babica, Alma Mihaljevic Pelesb, Miro Jakovljevicb and Nela Pivac

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 5, 1 July 2008, Pages 1195-1198

 

3 - Combination therapy with amisulpride and antidepressants: Clinical observations in case series of elderly patients with psychotic depression

Antonis M. Politisa, George N. PapadimitriouCorresponding Author Contact Information, a, E-mail The Corresponding Author, Christos G. Theleritisa, Constantin Psarrosa and Constantin R. Soldatos

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 5, 1 July 2008, Pages 1227-1230

 

3 - Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

Ruth Dixon, Sarah Job, Ruth Oliver, Debra Tompson, John G Wright, Kay Maltby, Ulrike Lorch, Jorg Taubel

British Journal of Clinical Pharmacology Published Online: 28 Jun 2008

 

GRATIS 3 - Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group

National Guideline Clearinghouse June 2008

 

5 - Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study

Gregory H. Pelton, Oliver L. Harper, Matthias H. Tabert, Harold A. Sackeim, Nikolaos Scarmeas, Steven P. Roose, D. P. Devanand

International Journal of Geriatric Psychiatry. Volume 23 Issue 7, Pages 670 - 676

 

3! - Depressed Patients With Co-Occurring Alcohol Use Disorders: A Unique Patient Population

Leo Sher, Barbara H. Stanley, Jill M. Harkavy-Friedman, Juan J. Carballo, Mikkel Arendt, David A. Brent, Dahlia Sperling, Dana Lizardi, J. John Mann, and Maria A. Oquendo

J Clin Psychiatry 2008;69:907-915

 

3 - Case-Control Analyses of the Impact of Pharmacotherapy on Prospectively Observed Suicide Attempts and Completed Suicides in Bipolar Disorder: Findings From STEP-BD

Lauren B. Marangell, Ellen B. Dennehy, Stephen R. Wisniewski, Mark S. Bauer, Sachiko Miyahara, Michael H. Allen, Melissa Martinez, Rayan K. Al Jurdi, and Michael E. Thase

J Clin Psychiatry 2008;69:916-922

 

3 - An Open-Label, Prospective Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Long-Term Treatment of Refractory Depression: Reproducibility and Duration of the Antidepressant Effect in Medication-Free Patients

Asli Demirtas-Tatlidede, Dawn Mechanic-Hamilton, Daniel Z. Press, Chester Pearlman, William M. Stern, Mark Thall, and Alvaro Pascual-Leone

J Clin Psychiatry 2008;69:930-934

 

3! - Is Bipolar Disorder Overdiagnosed?

Mark Zimmerman, Camilo J. Ruggero, Iwona Chelminski, and Diane Young

J Clin Psychiatry 2008;69:935-940

 

3 - Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: Diagnostic- and Symptom-Guided Drug Selection

Somaia Mohamed, and Robert A. Rosenheck

J Clin Psychiatry 2008;69:959-965

 

3 - A Cross-Sectional Evaluation of Perimenopausal Depression

Emma M. Steinberg; David R. Rubinow, John J. Bartko, Paige M. Fortinsky, Nazli Haq, Karla Thompson, and Peter J. Schmidt

J Clin Psychiatry 2008;69:973-980

 

3! - Metabolic syndrome in Italian patients with bipolar disorder

Virginio Salvi, Umberto Albert, Alice Chiarle, Isabella Soreca, Filippo Bogetto and Giuseppe Maina

General Hospital Psychiatry. Volume 30, Issue 4, July-August 2008, Pages 318-323

 

5 - Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis

W W van den Broek, P G H Mulder, E van Os, T K Birkenhäger, E Pluijms, and J A Bruijn

Journal of Psychopharmacology. First published on June 18, 2008

5< - Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial

C K Martin, H Han, S D Anton, F L Greenway, and S R Smith

Journal of Psychopharmacology First published on June 26, 2008

 

3 - Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial

S Englisch, U Knopf, B Scharnholz, A Kuwilsky, M Deuschle, and M Zink

Journal of Psychopharmacology First published on June 26, 2008

GRATIS 3! - Perinatal depression: treatment options and dilemmas

Teri Pearlstein

J Psychiatry Neurosci 2008;33(4):302-18

 

3! - Factors Associated With Prospective Long-Term Treatment Adherence Among Individuals With Bipolar Disorder

Martha Sajatovic, Kousick Biswas, Amy K. Kilbourne, Howard Fenn, William Williford, and Mark S. Bauer

Psychiatr Serv 59:753-759, July 2008

GRATIS 3! - Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability?

Claudio N. Soares, Brook Zitek

J Psychiatry Neurosci 2008;33(4):331-43

 

3! - A role for nuclear β-catenin in SNRI antidepressant-induced hippocampal cell proliferation

Ricardo Mostany, Elsa M. Valdizán and Angel Pazos

Neuropharmacology. Volume 55, Issue 1, July 2008, Pages 18-26

 

5! - Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence

J. Craig Nelson, Kevin Delucchi, and Lon S. Schneider

Am J Geriatr Psychiatry 16:558-567, July 2008

GRATIS 3 - Emsam (selegiline transdermal system) Patches

FDA Center for Drug Evaluation and Research (CDER)

Summary View: Safety Labeling Changes - February 2008

 

GRATIS 3 - Effexor XR (venlafaxine hydrochloride) Extended-Release Capsules

FDA Center for Drug Evaluation and Research (CDER)

Summary View: Safety Labeling Changes - February 2008

 

3! - Maintenance Treatment with Fluoxetine is Necessary to Sustain Normal Levels of Synaptic Markers in an Experimental Model of Depression: Correlation with Behavioral Response

Analía Reinés, Marina Cereseto, Alejandro Ferrero, Laura Sifonios, Maria Fernanda Podestá and Silvia Wikinski

Neuropsychopharmacology (2008) 33, 1896–1908

 

3! - Functional Coupling of the Amygdala in Depressed Patients Treated with Antidepressant Medication

Chi-Hua Chen, John Suckling, Cinly Ooi, Cynthia H Y Fu, Steve C R Williams, Nicholas D Walsh, Martina T Mitterschiffthaler, Emilio Merlo Pich and Ed Bullmore

Neuropsychopharmacology (2008) 33, 1909–1918

 

GRATIS 3! - Personality and Differential Treatment Response in Major Depression: A Randomized Controlled Trial Comparing Cognitive-Behavioural Therapy and Pharmacotherapy

R Michael Bagby, Lena C Quilty, Zindel V Segal, Carolina C McBride, Sidney H Kennedy, Paul T Costa

Can J Psychiatry 2008;53(6):361–370

 

GRATIS 3 - Advances in the Treatment of Late-Life Psychotic Depression

Gary J. Kennedy

Primary Psychiatry. 2008;15(7):27-29

.

Regresar a RESÚMENES JUNIO 2008

.

© 1999-2008 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.